Package 55253-801-30

{"route": ["ORAL"], "spl_id": "428b6de2-f791-43db-a186-d19312a348fd", "openfda": {"nui": ["N0000175729", "N0000175651", "N0000175769"], "unii": ["R3UK8X3U3D"], "rxcui": ["205324", "260218"], "spl_set_id": ["9f3b0bd2-72a3-411f-aeec-b533373f1a97"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]", "Increased Sympathetic Activity [PE]"], "pharm_class_epc": ["Sympathomimetic-like Agent [EPC]"], "manufacturer_name": ["CIMA LABS INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (55253-801-30)", "package_ndc": "55253-801-30", "marketing_end_date": "20270331", "marketing_start_date": "20120329"}], "brand_name": "Modafinil", "product_id": "55253-801_428b6de2-f791-43db-a186-d19312a348fd", "dosage_form": "TABLET", "pharm_class": ["Central Nervous System Stimulation [PE]", "Increased Sympathetic Activity [PE]", "Sympathomimetic-like Agent [EPC]"], "product_ndc": "55253-801", "dea_schedule": "CIV", "generic_name": "Modafinil", "labeler_name": "CIMA LABS INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Modafinil", "active_ingredients": [{"name": "MODAFINIL", "strength": "100 mg/1"}], "application_number": "NDA020717", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_end_date": "20270331", "marketing_start_date": "20120329"}